logowebretinalogowebretinalogowebretinalogowebretina
  • Home
  • About us
  • Health Professionals
  • Library
  • News
  • Contact
✕
Biotech Spain: Interview with Andreu Climent, Associate Founder and CEO of Corify Care
22 September, 2021
CORIFY CARE, awarded as the Best Startup of the year by 2021 Disruptores e Innovadores awards
11 April, 2022
30 September, 2021

CORIFY CARE participates in the Atrial Signals workshop 2021

Atrial1
Last week (23-25th September) took place the workshop Atrial Signals 2021 http://www.atrial-signals.kit.edu/ at the Karlsruhe Institute of Technology (KIT), thanks to the joint collaboration of the Institute of Biomedical Engineering (IBT) and the Städtisches Klinikum Karlsruhe. Andreu Climent, CEO of Corify Care presented Acorys, our Non-invasive Electrocardiographic Imaging device of the electrical activity of the heart, which allows a personalized and optimal diagnosis and treatment to each patient.

María S. Guillem, professor at ITACA Institute of the Universitat Politecnica de Valencia and Chief Scientific Officer of Corify Care, presented the latest advances of the signal processing. Likewise, Professor Guillem shared the progress of the PersonalizeAF project (https://personalizeaf.net/), a Marie S. Curie action coordinated by her. PersonalizeAF counts on the participation of Karlsruhe Institute of Technology (KIT), the Maastricht University, the Bordeaux University, the Oxford University, the Bologna University, Simula Research Laboratory, the August Pi Sunyer Biomedical Research Institute (IDIBAPS), La Fe Health Research Institute and the Medicine University of Freiburg.

The Atrial Signals 2021 agenda comprised more than 60 invited talks by renowned experts in the field. The sessions covered topics like the Arrhythmogenic Substrate, Atrial Signals – Novel Technologies, the Best Mapping Strategy, the Best Ablation Targets and the Best Ablation Strategy, etc.

For Corify Care has been an honour to participate in this workshop together with the best clinicians and engineers to address the posed challenge of treatment of atrial fibrillation.

Atrial2

Related posts

2 February, 2023

Protected: ACORYS IFU 1.0


Read more
2 February, 2023

Protected: PDF


Read more
19 January, 2023

Corify obtiene financiación de Red.es para el proyecto ai.cor


Read more

News

  • Protected: ACORYS IFU 1.0
    2 February, 2023
CALL US

+34 910 888 183

OR WRITE

corify@corify.es

Twitter

Retweet on Twitter Corify Care Retweeted
Innovaspain @innovaspain ·
6 Feb

#ACORYS: el mapeo del corazón definitivo para tratar con éxito la arritmia cardiaca

Hablamos con @amcliment, CEO de @corifyAF, la empresa que junto a la @UPV ha validado en un ...estudio científico las capacidades del “electrocardiograma del siglo XXI”

https://www.innovaspain.com/acorys-el-mapeo-del-corazon-definitivo-para-tratar-la-arritmia-cardiaca/

Reply on Twitter 1622560282122850304 Retweet on Twitter 1622560282122850304 2 Like on Twitter 1622560282122850304 3 Twitter 1622560282122850304
2020 Corify. All Rights Reserved. Privacy